Covariate | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95%CI | p-value | HR | 95%CI | p-value | |
Sex, Male | 1.223 | 0.899–1.662 | 0.200 |  |  |  |
Age, ≥ 60 years | 1.379 | 1.032–1.843 | 0.030* |  |  |  |
IPI, 3–5 | 3.124 | 2.265–4.307 |  < 0.05* |  |  |  |
ECOG, 3–5 | 3.775 | 2.820–5.054 |  < 0.05* | 2.351 | 1.647–3.356 |  < 0.05* |
Stage, III–IV | 7.859 | 3.862–15.993 |  < 0.05* | 3.276 | 1.512–7.099 |  < 0.05* |
B symptoms | 2.101 | 1.542–2.862 |  < 0.05* |  |  |  |
Bone marrow | 3.062 | 2.297–4.082 |  < 0.05* |  |  |  |
Involvement Albumin, < 35 g/L | 2.209 | 1.656–2.946 |  < 0.05* |  |  |  |
EBV, Positive | 1.390 | 1.024–1.887 | 0.035* |  |  |  |
Extra-nodal, > 1 | 3.207 | 2.374–4.331 |  < 0.05* | 1.659 | 1.125–2.445 | 0.039* |
LY(× 109/L) < 0.8 | 2.279 | 1.706–3.045 |  < 0.05* |  |  |  |
MONO(× 109/L) > 1 | 2.292 | 1.492–3.523 |  < 0.05* |  |  |  |
PLT(× 109/L) < 83 | 3.459 | 2.471–4.841 |  < 0.05* |  |  |  |
Elevated LDH | 1.613 | 1.182–2.200 |  < 0.05* |  |  |  |
Elevated β2-MG | 2.159 | 1.560–2.986 |  < 0.05* |  |  |  |
LMR ≤ 1.68 | 3.496 | 2.617–4.669 |  < 0.05* | 1.751 | 1.158–2.647 |  < 0.05* |
PMR ≤ 300 | 3.947 | 2.947–5.287 |  < 0.05* | 1.762 | 1.201–2.586 |  < 0.05* |